I'll research PSX before writing the preview. Let me start by gathering recent filings, transcripts, and news.Let me read the most recent earnings materials and gather more context.This is a rich, unusual macro backdrop (Middle East crisis / Strait of Hormuz closure driving elevated margins). Let me gather the YoY comparison quarter, recent news, and stock price action.Let me pull recent energy/macro topic news to characterize the margin backdrop heading into the print.I now have a comprehensive picture. Let me verify a couple of stock-performance figures before writing.Here is the earnings preview.
PSX heads into this print riding the most extraordinary refining tape in years. A months-long, war-driven disruption of Middle East supply — including the effective closure of the Strait of Hormuz — has blown out global refining and petrochemical margins, and PSX's overwhelmingly U.S.-based footprint is a direct beneficiary. The stock reflects it: PSX is up ~58% year-to-date to ~$206, sitting ~3% below its July 21 high of ~$212. Expectations are now very high, so this quarter is less about whether numbers are strong and more about how strong, how durable, and how fast the balance sheet heals.
On the Q1 call, PSX gave the following Q2 markers: - Refining crude utilization: low-to-mid 90s% - Refining turnaround expense: $120–150M (down from $178M in Q1) - Chemicals global O&P utilization: low-80s% — deliberately lower than Q1's 94%, reflecting downtime at CPChem's Middle East JVs - Corporate & Other costs: $430–450M - Refining market capture: "start with mid-90s%" and adjust for market conditions (vs. a remarkable 138% worldwide capture in Q1)
Q1 was depressed by an $839M pre-tax mark-to-market loss on short derivative hedges (Refining −$396M, M&S −$323M, Renewables −$120M) as commodity prices spiked — paper losses against physical inventory carried at LIFO. This is the key reason Q1 adjusted EPS was only $0.49.
Management said that, using the forward curve, roughly $500M of that $839M would recover by year-end, on a commodity-by-commodity, quarter-by-quarter basis. As prices stabilized in Q2 (crude traded in a ~$90–110 band), some of that reversal should flow back through Refining, M&S, and Renewables — a potential earnings tailwind on top of the strong underlying cracks. How much reverses in Q2 is a material variable in the headline number and a likely focus of Q&A.
Refining (the swing engine). Strong cracks + reduced turnarounds + possible MtM reversal should drive a large sequential and YoY jump (Q1 adjusted pre-tax was just $208M; Q2 2025 was $392M). Key watch items: - Market capture — Q1's commercial machine (Jones Act moves, pre-booked time charters, jet/octane diffs) drove 138%; a repeat well above "mid-90s" would be a positive surprise. - WCS discounts — WTI-WCS blew out to ~$18. PSX's Mid-Con/pipeline position gives it ~$140M of incremental earnings per $1 of wider diff — a powerful, under-appreciated lever. - Cost progress — Q1 cost/bbl was $6.21 ($5.80s normalized), tracking toward the $5.50/bbl 2027 target.
Chemicals (CPChem). Margins are tightening sharply (advantaged U.S. Gulf Coast ethane vs. rising global naphtha; loss of China's discounted-crude advantage). But utilization guided to low-80s on ME JV downtime, so watch the volume-vs.-margin trade-off.
Renewable Fuels (potential YoY inflection). RIN values are running more than double 2025 levels and the Rodeo plant is running above nameplate. After a string of losses, this segment could show a material free-cash-flow swing — a possible under-the-radar bright spot.
Midstream (the ballast). Steady, fee-based; reaffirmed $4.5B EBITDA target by 2027. Watch DJ Basin record volumes, LPG export strength (Freeport), and any commentary on associated-gas growth feeding Sweeny.
Marketing & Specialties. Q1 loss was almost entirely MtM-driven; a reversal plus summer driving demand should restore this to solidly positive.
This is where the bull/bear debate really lives: - Debt spiked to $27.1B at end-Q1 (from $19.7B at YE 2025), net debt/cap at 43%, because PSX grossed up the balance sheet to fund $3.2B of margin collateral during the price spike. By late April that collateral had already fallen to ~$2.1B. - The healing path: management expects working-capital reversal (Q1 had a ~$3B WC drag), operating cash flow, and drawdown of the elevated cash balance ($5.2B) to cut debt to ~$19B by YE 2026 and $17B by YE 2027. Evidence of that trajectory bending down this quarter is arguably the most important thing in the release. - Capital returns intact: commitment to return >50% of operating cash flow; the dividend was raised 7% in Q1. With cash generation surging, watch whether buybacks step up (Q1 repurchases were a modest $269M) or whether excess cash is steered toward faster deleveraging — management signaled a "balanced" approach but flagged debt reduction as the priority.
A blowout headline number looks likely given the margin environment and the MtM reversal tailwind, but the quality of the beat and the balance-sheet trajectory will drive the reaction. Going in, focus on:
| Watch item | Bullish signal | Bearish signal |
|---|---|---|
| Refining capture | Well above "mid-90s," strong WCS capture | Backwardation/inventory drag pulls capture down |
| MtM reversal | Meaningful chunk of the $839M flows back | Limited reversal, muddier earnings quality |
| Debt path | Clear move toward $19B YE target | Debt/collateral stays elevated |
| Capital returns | Buyback step-up alongside dividend | Cash hoarded, ambiguous framework |
| Margin duration | Confident "persists into 2027" case | Cautious tone as Hormuz reopening nears |
| Western Gateway | FID announced | Slippage/no decision |
Note: figures and the macro backdrop above are drawn from PSX's Q1 2026 and Q2 2025 earnings releases and the Q1 2026 call transcript, plus recent market/sector news; consensus-estimate specifics were not independently confirmed here.